Avian Influenza: Information for Health Professionals and Laboratorians
CDC is currently updating some avian influenza guidance documents, which will be posted to this page as they are finalized. Where only avian H7N9 guidance is available, it is appropriate to use avian H7N9 guidance to address other avian influenza infections in people.
Testing and Reporting
- Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
- Interim Guidance for Specimen Collection, Processing, and Testing for Patients with Suspected Infection with Novel Influenza A Viruses Associated with Severe Disease in Humans
- Diagnostics for Detecting H7N9 Using rRT-PCR
- CDC and USDA Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses
- World Health Organization (WHO) Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease Interim recommendations [PDF, 74 KB]
Treatment and Prophylaxis
Treatment
Chemoprophylaxis of Persons with Bird Exposure
Chemoprophylaxis of Close Contacts
Case Definitions
HPAI H5 Viruses in U.S. Birds
H5N1
- Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus in the United States January 13, 2014
H7N9
- Interim Guidance on Case Definitions for Investigations of Human Infection with Avian Influenza A (H7N9) Virus in the United States January 13, 2014
HAN: CDC Health Advisories
Vaccine Development
H5N1
- Candidate vaccine viruses and potency testing reagents for influenza A (H5N1), WHO
- Making a Candidate Vaccine Virus (CVV) for a Highly Pathogenic Avian Influenza (Bird Flu) Virus
H7N9
- Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO
- Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus [PDF, 604 KB]
CDC Expert Commentary on Medscape
Title: The New Avian Influenza A (H7N9) Virus: What Clinicians Should Know
Posting Date: Thursday, May 09, 2013
Faculty: Alicia M. Fry, MD, MPH
- Page last reviewed: July 28, 2017
- Page last updated: July 28, 2017
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs